CalciMedica, Inc. 8-K

What Happened

• On May 12, 2026, CalciMedica, Inc. (CALC) filed a Form 8-K (Item 2.02) to announce its financial results for the fiscal quarter ended March 31, 2026. The company issued a press release with those results, which is attached to the filing as Exhibit 99.1. The report was signed by CEO A. Rachel Leheny, Ph.D.

Key Details

• Filing date: May 12, 2026.
• Reporting period: fiscal quarter ended March 31, 2026.
• Press release with the quarterly results is attached as Exhibit 99.1 to the 8-K.
• Form 8-K was signed by CEO A. Rachel Leheny, Ph.D.

Why It Matters

• This 8-K signals that CalciMedica has publicly disclosed its latest quarterly results (earnings), which may include revenue, profit/loss, cash position and management commentary. Investors should read the attached press release for the specific figures and any forward-looking statements or guidance. These results can impact near-term investor sentiment and trading, and they will be important context ahead of any subsequent periodic filings (e.g., the company’s next 10-Q).